My ePortfolio Register   

Elucidation and pharmacological targeting of tumour checkpoint dependencies

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Submit
Thanks for rating
There has been a problem, please refresh and try again.
Published: 28.04.16
Views: 1607
Rating:

Dr Andrea Califano - Colombia University Medical Centre, New York, USA

Dr Andrea Califano speaks with ecancertv at AACR 2016 to summarise recent developments in cancer research and advances in checkpoint research.

From past therapies to modern immunotherapy, Dr Califano looks forward to the next potential steps in cancer management; mechanistic targets, tumour checkpoints and cell regulators.

By developing comprehensive models of cell behaviours with which to forecast drug efficacy and identify oncogenic sources, he describes the potential of near-future therapies to single out the root causes of cancer, before they manifest as malignancies.

Dr Califano will also be a keynote speaker at the WIN consortium meeting in Paris and you can hear more on his upcoming talk in this interview with WIN chairman Dr John Mendelsohn.

Related videos

follow us



Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence